Teriflunomide

Teriflunomide is the active metabolite of leflunomide, and it functions as a immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated to treat multiple sclerosis, specifically relapsing forms. The FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as multiple sclerosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Flucyamide, Aubagio and teriflunomidum. Its PubChem CID is 54684141.

CAS No 163451-81-8
Molecular Formula C12H9F3N2O2
Molecular Weight 270.21 g/mol
Synonyms (Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide

Frequently Asked Questions